Last updated: March 2, 2026
What Are the Patent’s Core Claims and Scope?
Patent IL225789 is a pharmaceutical patent granted in Israel. It claims a specific drug composition, method of treatment, or formulation, depending on its detailed description. Based on typical patent structures, the scope generally covers:
- Active Ingredient(s): The chemical compound or combination presented as the therapeutic agent.
- Methods of Manufacturing: The process involved in producing the drug.
- Treatment Methods: Specific methods for using the drug to treat particular conditions.
- Formulations: Specific dosage forms, carriers, or delivery systems.
Exact claims depend on the patent text but typically include a combination of these elements, with claims ranging from broad to narrow.
Claim Types and Their Breadth
- Independent Claims: Usually define the core invention, such as a novel compound or method, with broad language to cover similar variants.
- Dependent Claims: Narrower, specify particular embodiments, such as specific dosages, formulations, or treatment regimens.
The scope's breadth influences enforceability and patent strength: broader claims provide wide coverage but may be easier to invalidate for prior art; narrower claims are easier to defend but limit exclusivity.
Patent Landscape Overview
Geographic Coverage
- Israel: Patent IL225789 grants protection within Israel.
- International Filings: Filing strategies may include Patent Cooperation Treaty (PCT) applications, filings in major markets (US, EU, China), or regional patent offices to expand patent protection.
Related Patents and Prior Art
- Prior Art Search: Typically reveals related compounds, formulations, or treatment methods. Similar patents may have been filed in the areas of oncology, neurology, or autoimmune diseases, depending on the drug class.
- Patent Families: A patent family likely exists if the applicant sought broader or regional protection. Cross-referencing family members helps identify core patent rights and expiry timelines.
Patent Examining Bodies and Legal Status
- Examining Authority: The Israeli Patent Office (ILPO) examined IL225789.
- Legal Status: Check whether the patent is active, under opposition, or expired. Active status currently allows enforcement and licensing.
Legal and Commercial Implications
- Enforceability: The narrowness or breadth of the claims affects legal robustness.
- Infringement Risks: Other drugs with similar compositions or methods could infringe if they fall within the claims' scope.
- Market Strategy: Patent protection influences licensing, partnership, and R&D planning.
Summary of Competitive Landscape
- Peer Patents: Other patents granted or pending on similar compounds, delivery systems, or therapeutic methods.
- Major Patent Holders: Companies in the same therapeutic area may hold competing patents, affecting freedom-to-operate.
- Emerging Technologies: Innovations in drug delivery (e.g., nanotechnology, implantable devices) could impact patent strength and market potential.
Key Takeaways
- Patent IL225789 likely claims specific drug compositions, formulations, or treatment methods.
- The scope depends on claim language, affecting enforceability and market exclusivity.
- The patent’s landscape encompasses related patents, prior art, and regional filings.
- Legal status and patent family structures provide insight into protection duration and strength.
- Competitive analysis reveals potential infringement risks and licensing opportunities.
FAQs
1. How broad are the claims in IL225789?
The claims’ breadth depends on the language used; independent claims cover the core invention broadly, while dependent claims narrow the scope.
2. What is the geographic coverage of this patent?
IL225789 protects the drug only within Israel. To expand protection internationally, applicants typically file in other jurisdictions via PCT or regional applications.
3. When does patent IL225789 expire?
Patent term in Israel is typically 20 years from the filing date, subject to maintenance payments; specific expiry details require official status checks.
4. Can other companies develop similar drugs without infringing?
Only if their products fall outside the patent claims’ scope—e.g., different compound structures, formulations, or methods.
5. What is the likelihood of patent litigation around this patent?
Litigation risk depends on claim scope, market presence, and existing patents; broader claims increase infringement risk.
References
- Israeli Patent Office. (2022). Patent search reports and status.
- WIPO. (2021). Patent landscape reports.
- USPTO. (2022). Patent application procedures and policies.
- EPO. (2022). Patent classification and related patents.
- World Health Organization. (2022). Global patent information on pharmaceuticals.
